Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dermira Inc. (DERM)

10.5   -0.05 (-0.47%) 05-17 16:00
Open: 10.42 Pre. Close: 10.55
High: 10.82 Low: 10.42
Volume: 598,253 Market Cap: 564M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.845 - 10.899 10.899 - 10.942
Low: 10.274 - 10.346 10.346 - 10.404
Close: 10.4 - 10.508 10.508 - 10.596

Technical analysis

as of: 2019-05-17 4:27:48 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 13.64     One year: 14.92
Support: Support1: 9.92    Support2: 8.25
Resistance: Resistance1: 11.68    Resistance2: 12.77
Pivot: 10.63
Moving Average: MA(5): 10.39     MA(20): 10.80
MA(100): 9.41     MA(250): 10.04
MACD: MACD(12,26): -0.33     Signal(9): -0.31
Stochastic oscillator: %K(14,3): 28.67     %D(3): 25.81
RSI: RSI(14): 44.88
52-week: High: 15.48  Low: 6.00  Change(%): -2.8
Average Vol(K): 3-Month: 223233  10-Days: 70630

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
DERM has closed above bottom band by 41.7%. Bollinger Bands are 57% narrower than normal. The narrow width of the bands suggests low volatility as compared to DERM's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 13 May 2019 18:06:48 Z
5 Growthy Biotech Stocks to Buy Despite the Scrutiny

Wed, 08 May 2019 20:59:04 Z
Dermira (DERM) Q1 2019 Earnings Call Transcript

Wed, 08 May 2019 01:11:41 Z
Dermira (DERM) Reports Q1 Loss, Lags Revenue Estimates

Thu, 25 Apr 2019 17:23:10 Z
Dermira (DERM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Mon, 08 Apr 2019 23:06:50 Z
Here's Why Dermira Shot Up 62% in March

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 53.67
Shares Float (M) 53.47
% Held by Insiders
% Held by Institutions 94.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -5.240
EPS Est. Current Year -4.200
EPS Est. Next Year -3.890
EPS Est. Next Quarter -1.380
Forward EPS -4.927
Book Value (p.s.) 7.630
PEG Ratio -0.02
Profit Margin
Operating Margin -491.97
Return on Assets (ttm) -49.3
Return on Equity (ttm) -237.7
Qtrly Rev. Growth 720.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -226.93
Levered Free Cash Flow (M) -254.14

Stock Valuations

P/E -2.00
P/E Growth Ratio
P/BV 1.38
P/S 536700000.00
P/CF -2.48

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.